Wafer formulation
US8623401B2 · kind B2 · utility
17Cited by
1References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 27, 2008 |
| Grant date | Jan 7, 2014 |
| Priority date | — |
| Expiry date | May 22, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An orally administrable wafer is provided comprising at least one physiologically acceptable film forming agent. The wafer is formed by mixing the film-forming agent with an aqueous solution to form a gel and exposing the gel to a plurality of heating and cooling cycles. The wafer is rapidly dissolving and suitable for administration of pharmaceutical agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.